Contineum Therapeutics Debt/Equity Ratio 2023-2024 | CTNM

Contineum Therapeutics debt/equity ratio from 2023 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Contineum Therapeutics Debt/Equity Ratio 2023-2024 | CTNM

Contineum Therapeutics debt/equity ratio from 2023 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.